Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.
about
Opioid antagonists for smoking cessationThe effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature reviewA randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology.Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.Translational Research on Nicotine Dependence.Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings.Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phaseGender Considerations in Addiction: Implications for Treatment.Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokersEffects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialEndogenous opioid system: a promising target for future smoking cessation medications.Naltrexone for the treatment of comorbid tobacco and pornography addiction.Nociceptin/orphanin FQ receptor gene variation is associated with smoking status in Japanese.Sex and gender differences in substance use disorders.Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia.
P2860
Q24202118-2CF8C3B8-E49E-438D-94C4-2BBB9289FF6CQ33892368-94F91085-85F7-4BFB-A28D-61D6F8A6A385Q34111646-431B5B40-F9D3-4C9B-AFDC-4574AB8A0069Q34133292-5D851992-BC53-4D26-8DC1-13A6AED5F2DAQ34167551-8F273DCB-D5BD-46AB-BEA1-CC91E225B12BQ34513939-5CF75C8F-F34E-4C70-923E-70F62B6AC855Q35195302-D020112A-77EE-43D2-B1D8-E7C73F2E20CFQ35786999-6319DC36-DFE0-4868-B3CC-85BF9BDF3264Q36082618-CAE03FA5-3118-47FB-A59F-4CA5F2C695ECQ36877440-65EEC86A-6AA5-4708-92B7-24302EFA5A30Q37179217-382C6DE0-0F51-4326-A619-BB1B54BF215EQ38747115-B9182446-91CB-47BE-B89E-8D6DEEC76BF0Q38768062-AD5EA9D0-CBAA-460B-B60D-63E694D07CB5Q40636095-6EFC2B9C-D250-46F9-AB3F-45C0EA665BD0Q47573027-3B26719D-E4B5-478D-B204-9C756DB9D2F1Q51244728-5DBA25A2-3F7C-4A7C-8E13-90081DE9452B
P2860
Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Naltrexone reduction of long-t ...... a randomized controlled trial.
@ast
Naltrexone reduction of long-t ...... a randomized controlled trial.
@en
type
label
Naltrexone reduction of long-t ...... a randomized controlled trial.
@ast
Naltrexone reduction of long-t ...... a randomized controlled trial.
@en
prefLabel
Naltrexone reduction of long-t ...... a randomized controlled trial.
@ast
Naltrexone reduction of long-t ...... a randomized controlled trial.
@en
P2093
P2860
P1476
Naltrexone reduction of long-t ...... a randomized controlled trial
@en
P2093
Andrea C King
Dingcai Cao
Stephanie S O'Malley
P2860
P304
P356
10.1016/J.BIOPSYCH.2012.09.025
P407
P577
2012-11-22T00:00:00Z